Search For "anda applicants"
Glenmark Pharmaceuticals launches Rufinamide Tablets USP, 200 mg and 400 m
Updated : 4 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 1 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark) has launched Rufinamide Tablets USP, 200 mg and 400 mg, a therapeutic equivalent of Banzel® Tablets, 200 mg and 400 mg of Eisai, Inc.
Read More